신화콘텍 Stock: price and insider trades · South Korea
No insider purchase over the last 90 days. The latest, by 이동규, was filed 08 Apr 2025.
신화콘텍: what insiders have been doing
Every trade that managers of 신화콘텍 disclose to DART (FSS) is tracked on this page. The company sits in the Technology sector. The past year has been quiet: not a single insider filing for 신화콘텍. The previous disclosure was published on 8 April 2025.
Over the whole record (from 2021), the tally stands at 3 purchases and 9 sales.
Other companies in the same sector with recent insider buying flagged by our signals: Basler Aktiengesellschaft and Lime Technologies AB (publ). This summary is built from DART (FSS) disclosures alone and does not predict where the share price will go.
Who traded when
BuySaleTransparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- Other0DART
- 98,000 sharesShareKRXDART:20250408000283Canonical exit: 7 Jul 2025 (T+90)
- 45,555 sharesKRXDART:20250408000243
- ●Executives0DART
- 5,555 sharesKRXDART:20241129000867Canonical exit: 26 Feb 2025 (T+90)
- 284,050 sharesKRXDART:20241008000364
- 284,050 sharesKRXDART:20230410002383
- 67,140 sharesKRXDART:20230110000610Canonical exit: 10 Apr 2023 (T+90)
- 284,050 sharesKRXDART:20220628000262
- ShareKRXDART:20220615000414
- ShareKRXDART:20220523000351
- 284,050 sharesKRXDART:20220523000357
- ShareKRXDART:20220516001579
- ●Executives0DART
- ●Executives0DART
- ShareKRXDART:20210827000797
- 284,050 sharesKRXDART:20210827000804
- ShareKRXDART:20210810000338
- 284,050 sharesKRXDART:20210709000530
- ShareKRXDART:20210709000523
- ShareKRXDART:20210707000475
- ShareKRXDART:20210707000465
- ShareKRXDART:20210518000332
- 284,050 sharesKRXDART:20210518000320
- 284,050 sharesKRXDART:20210514001466
25 of 26 declarations
About 신화콘텍
신화콘텍 is a technology company listed on the XKRX. It specializes in developing innovative technology solutions.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
